SCYX
SCYNEXIS Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$0.822
Máximo
$0.822
Mínimo
$0.822
Volume
0.05M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical holdResumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme.Hansoh recently
Ações relacionadas
PFIS
Peoples Financial Services Corp.
AWH
Aspira Women's Health Inc.
IMMR
Immersion Corporation
GFS
GlobalFoundries Inc. Ordinary Shares
DHCNL
Diversified Healthcare Trust 6.25% Senior Notes Due 2046
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.